Boeing Co (BA) · Oct 27, 2026 · Earnings
Miss — Core loss/share $0.34 vs published estimates around $0.21-$0.24 loss
Boeing’s third-quarter earnings show improving cash flow and backlog, but a deeper-than-expected core loss keeps the commercial turnaround unfinished.
Boeing is rebuilding its commercial-aircraft production system after years of quality, certification, and supplier disruption, while leaning on defense and services for stability. The 737 is being ramped toward 47 aircraft per month, the 777X remains a 2027 program, and the Spirit integration is part of the effort to bring more manufacturing control in-house.
The quarter was weaker than the headline recovery suggests. Revenue of $24.2 billion was close to published estimates ranging from roughly $24.0 billion to $24.6 billion, but core loss per share of $0.34 was worse than the roughly $0.21-$0.24 loss expected. The company returned to positive operating income, yet it still lost $116 million on a GAAP basis and $203 million attributable to common shareholders after preferred dividends. 〔0〕
| Metric | Q3 2026 | Q3 2025 | Read-through |
|---|---|---|---|
| Revenue | $24.2B | $23.3B | Up 4%; near published expectations |
| Core loss per share | $(0.34) | $(7.47) | Worse than roughly $(0.21)-$(0.24) expected |
| Operating cash flow | $1.5B | $1.1B | Improved, partly from working-capital timing |
| Free cash flow | $0.5B | $0.2B | Positive for the quarter, still $(0.4)B year to date |
| Commercial Airplanes operating loss | $(697)M | $(5.4)B | Better year over year, but still the main drag |
| Defense operating earnings | $492M | $114M | Stronger, helped by a $252M asset-sale gain |
| Global Services operating earnings | $1.0B | $938M | Steady profit engine |
| Total backlog | $745.4B | $682.2B at year-end 2025 | Record demand, not yet equivalent to profitable delivery |
Commercial aviation remains the unresolved problem. Commercial Airplanes delivered 161 jets, essentially flat year over year, while revenue fell 3% to $10.7 billion and the operating margin remained negative at 6.5%. Boeing attributed the loss to unfavorable delivery mix, future production-rate adjustment costs, and higher supply-chain estimates. The certifications of the 737-7 and 737-10 are genuine execution milestones, but this quarter says the certification progress has not yet translated into clean commercial-aircraft profitability.
Defense and services are carrying more of the business than the headline backlog does. Defense revenue rose 15% and operating earnings more than quadrupled, although the quarter included the $252 million gain from the HRL Laboratories sale. The F/A-XX selection and PAC-3 contract expand the strategic pipeline, but the fighter award is not yet included in backlog. Global Services also produced $1.0 billion of operating earnings at an 18.3% margin, helping offset commercial losses.
Cash generation improved, but the balance-sheet repair is not finished. Quarterly operating cash flow was $1.5 billion and free cash flow was $464 million, despite approximately $700 million of Department of Justice settlement payments. However, nine-month free cash flow remained negative $359 million, debt stayed at $45.9 billion, and the company repaid $8.4 billion of debt during the first nine months. Positive quarterly cash flow is progress, but it is not yet proof that Boeing can sustainably fund its production ramp without continued balance-sheet pressure.
The backlog is supportive but not a near-term earnings fix. Total backlog reached $745.4 billion, including $611.8 billion in Commercial Airplanes and $100.5 billion in Defense, Space & Security. That demand gives Boeing a long runway if it can execute, but the current quarter shows the bottleneck is converting orders into aircraft at acceptable cost and margin, not finding customers.
Bottom line: Boeing is making operational progress, especially in cash flow, certifications, defense, and backlog. But the core earnings miss and continuing 737 losses show the commercial turnaround is still a work in progress rather than a clean financial inflection point.
777X first delivery targeted for 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!